Axillary surgical de-escalation after neoadjuvant therapy in breast cancer: current evidence, clinical controversies, and future directions
{{output}}
Neoadjuvant therapy (NAT) has expanded opportunities to de-escalate axillary surgery in breast cancer, but the appropriate extent of surgery remains uncertain across pretreatment nodal stages and post-treatment responses. This focused narrative review synthesi... ...
